The impact of early oral anticancer medication monitoring through electronic patient assessments

American Journal of Health-System Pharmacy 2026 Open access

Read full text
Authors: Brooke D. Looney, Tiffany Bui, Josh DeClercq, Kristen Whelchel, Leena Choi, Autumn D. Zuckerman
DOI: 10.1093/ajhp/zxag070
Cited by: 0
References: 34

Abstract

PURPOSE: This study evaluated the effectiveness of electronic early oral anticancer medication monitoring questionnaires in identifying adverse effects (AEs) requiring pharmacist intervention among patients initiated on oral anticancer therapy. METHODS: A prospective randomized study was conducted within an integrated health system specialty pharmacy. Patients were excluded if they never started treatment, discontinued oral anticancer therapy within 14 days, were not new to therapy, or had a hematologic condition. Stratified randomization by age (≥60 years versus

Fields of Study & Subjects

Pharmacy and Medical Practices Pharmaceutical Practices and Patient Outcomes Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
American Journal of Health-System Pharmacy
Volume
83
Issue
17
Pages
e637–e648
Publication date
6 March 2026
Language
EN